baicalin has been researched along with Choline Deficiency in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gong, X; Hu, J; Kuang, G; Liu, J; Wan, J; Wu, S; Yin, X; Yuan, Y; Zhang, L; Zhang, X; Zhou, Q | 1 |
| Deng, X; Li, G; Liu, B; Xin, S; Xu, K; Zhang, H; Zhang, J; Zhang, N | 1 |
2 other study(ies) available for baicalin and Choline Deficiency
| Article | Year |
|---|---|
Baicalin and its nanoliposomes ameliorates nonalcoholic fatty liver disease via suppression of TLR4 signaling cascade in mice.
Topics: Animals; Choline Deficiency; Cytokines; Diet; Drug Liberation; Flavonoids; Liposomes; Liver; Male; Methionine; Mice, Inbred C57BL; Nanoparticles; Non-alcoholic Fatty Liver Disease; Toll-Like Receptor 4 | 2020 |
Baicalin attenuates non-alcoholic steatohepatitis by suppressing key regulators of lipid metabolism, inflammation and fibrosis in mice.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Caspase 3; Chemokine CCL2; Choline Deficiency; Diet; Flavonoids; Interleukin-1beta; Lipid Metabolism; Liver; Liver Cirrhosis; Liver Function Tests; Male; Methionine; Mice; Mice, Inbred C57BL; NF-kappa B; Non-alcoholic Fatty Liver Disease; Tumor Necrosis Factor-alpha | 2018 |